EFFECTS OF AN ORAL CONTRACEPTIVE AGENT ON PLASMA LIPIDS, PLASMA LIPOPROTEINS, THE INTRAVENOUS FAT TOLERANCE AND THE POST‐HEPARIN LIPOPROTEIN LIPASE ACTIVITY

Abstract
No abstract available